topotecan has been researched along with Carcinoma, Lewis Lung in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chepanova, AA; Chernyshova, IA; Dyrkheeva, NS; Ilina, ES; Lavrik, OI; Luzina, OA; Salakhutdinov, NF; Zakharenko, AL; Zakharova, OD | 1 |
| Kaledin, VI; Lavrik, OI; Luzina, OA; Nikolin, VP; Popova, NA; Salakhutdinov, NF; Zakharenko, AL | 1 |
| Kaledin, VI; Koldysheva, EV; Lavrik, OI; Lushnikova, EL; Luzina, OA; Men'shchikova, AP; Nikolin, VP; Popova, NA; Salakhutdinov, NF; Zakharenko, AL | 1 |
| Castiglioni, V; Cesca, M; Decio, A; Giavazzi, R; Rovida, A; Scanziani, E; Scarlato, V | 1 |
| Cui, J; Li, C; Wang, C; Wei, N; Yang, H; Zhao, X | 1 |
| Hansen, LT; Kristjansen, PE; Lund, EL | 1 |
6 other study(ies) available for topotecan and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Lewis Lung; DNA; DNA Damage; Mice; Phosphoric Diester Hydrolases; Topotecan | 2023 |
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.
Topics: Animals; Benzofurans; Carcinoma, Lewis Lung; Female; Male; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Topotecan | 2021 |
Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma.
Topics: Animals; Carcinoma, Lewis Lung; Enzyme Inhibitors; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Topotecan | 2019 |
Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Indoles; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Topotecan | 2013 |
Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Topics: Ammonium Sulfate; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Carcinoma, Lewis Lung; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Half-Life; Hand-Foot Syndrome; Humans; Injections, Intravenous; Leukemia L1210; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Prostatic Neoplasms; Random Allocation; Rats; Rats, Wistar; Skin; Skin Diseases; Tissue Distribution; Topoisomerase I Inhibitors; Topotecan | 2012 |
Augmenting tumor sensitivity to topotecan by transient hypoxia.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Small Cell; Cell Hypoxia; Cell Line, Tumor; Central Nervous System Neoplasms; Glioblastoma; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Nude; Topotecan; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2005 |